KE3427A - Long-acting parenteral compositions of haloperidol and bromoperidol derivatives - Google Patents

Long-acting parenteral compositions of haloperidol and bromoperidol derivatives

Info

Publication number
KE3427A
KE3427A KE3427A KE342784A KE3427A KE 3427 A KE3427 A KE 3427A KE 3427 A KE3427 A KE 3427A KE 342784 A KE342784 A KE 342784A KE 3427 A KE3427 A KE 3427A
Authority
KE
Kenya
Prior art keywords
bromoperidol
haloperidol
derivatives
long
parenteral compositions
Prior art date
Application number
KE3427A
Other languages
English (en)
Inventor
Niemegeers Carlos
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of KE3427A publication Critical patent/KE3427A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KE3427A 1979-06-28 1984-07-20 Long-acting parenteral compositions of haloperidol and bromoperidol derivatives KE3427A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8082679A JPS568318A (en) 1979-06-28 1979-06-28 Non oral long acting composition of haloperidol and bromperidol derivative

Publications (1)

Publication Number Publication Date
KE3427A true KE3427A (en) 1984-08-10

Family

ID=13729223

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3427A KE3427A (en) 1979-06-28 1984-07-20 Long-acting parenteral compositions of haloperidol and bromoperidol derivatives

Country Status (9)

Country Link
JP (1) JPS568318A (cs)
BE (1) BE883994A (cs)
CY (1) CY1255A (cs)
DE (1) DE3024305A1 (cs)
FR (1) FR2460932A1 (cs)
GB (1) GB2054371B (cs)
HK (1) HK83384A (cs)
KE (1) KE3427A (cs)
NL (1) NL190775C (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621892D0 (en) * 1986-09-11 1986-10-15 Lundbeck & Co As H Organic compound
DK238190D0 (da) * 1990-10-03 1990-10-03 Lundbeck & Co As H Depotderivater
DE669128T1 (de) * 1992-11-17 1996-03-14 Yoshitomi Pharmaceutical Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung.
WO1998018769A1 (en) * 1996-10-31 1998-05-07 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake
RU2178297C1 (ru) * 2001-02-02 2002-01-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая антипсихотическим и противорвотным действием, и способ ее получения
JP2008519840A (ja) 2004-11-10 2008-06-12 ジェンザイム・コーポレイション 糖尿病の処置方法
EP2923699B1 (en) 2006-05-09 2018-06-20 Genzyme Corporation Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis
EP2594564B1 (en) 2007-05-31 2016-09-28 Genzyme Corporation 2-acylaminopropanol-type glucosylceramide synthase inhibitors
CN102940627A (zh) 2007-10-05 2013-02-27 简詹姆公司 使用脑酰胺衍生物治疗多囊性肾疾病的方法
JP2011529500A (ja) 2008-07-28 2011-12-08 ジェンザイム コーポレーション 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害
KR101687039B1 (ko) 2008-10-03 2016-12-15 젠자임 코포레이션 2-아실아미노프로판올형 글루코실세라미드 합성효소 억제제
DK2685979T3 (da) 2011-03-18 2016-12-19 Alkermes Pharma Ireland Ltd Injicerbare farmaceutiske sammensætninger, omfattende et vand-uopløseligt, antipsykotisk sorbitanlaurat og polysorbat 20.
CN103301461B (zh) * 2012-03-08 2018-09-07 江苏豪森药业集团有限公司 一种长效注射制剂及其制备方法和用途
JP6333802B2 (ja) 2012-03-19 2018-05-30 アルカームス ファーマ アイルランド リミテッド ベンジルアルコールを含む医薬組成物
WO2013142202A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising glycerol esters
WO2013142198A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaaceutical compositions comprising fatty acid esters
NZ730571A (en) 2012-09-19 2018-12-21 Alkermes Pharma Ireland Ltd Pharmaceutical compositions having improved storage stability
MA39495A (fr) 2014-03-20 2015-09-24 Alkermes Pharma Ireland Ltd Formulations d'aripiprazole présentant des vitesses d'injection plus élevées
CN112423754A (zh) 2018-03-05 2021-02-26 奥克梅斯制药爱尔兰有限公司 阿立哌唑的给药策略
CN113117092A (zh) * 2020-01-14 2021-07-16 中国科学院上海药物研究所 一种非水缓释递药系统
HUP2100259A1 (hu) 2021-07-07 2023-01-28 Richter Gedeon Nyrt Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
DE1695194A1 (de) * 1966-07-11 1971-03-18 Hoffmann La Roche Verfahren zur Herstellung von Piperidinderivaten
US3850935A (en) * 1971-10-16 1974-11-26 Sumitomo Chemical Co Process for producing piperidine derivatives by degrading quaternary piperidinium salts

Also Published As

Publication number Publication date
FR2460932B1 (cs) 1984-11-16
NL8003583A (nl) 1980-12-30
NL190775B (nl) 1994-03-16
GB2054371B (en) 1983-08-03
DE3024305C2 (cs) 1989-12-07
NL190775C (nl) 1994-08-16
CY1255A (en) 1984-08-31
FR2460932A1 (fr) 1981-01-30
JPS568318A (en) 1981-01-28
BE883994A (fr) 1980-12-29
HK83384A (en) 1984-11-09
GB2054371A (en) 1981-02-18
DE3024305A1 (de) 1981-01-22

Similar Documents

Publication Publication Date Title
KE3427A (en) Long-acting parenteral compositions of haloperidol and bromoperidol derivatives
NZ192653A (en) 4-substituted piperidino-alkanol derivatives and pharmaceutical compositions containing them
AU536181B2 (en) Derivatives of camptothecin
PH17391A (en) Triazolthioalkyl substituted pleuromuilin derivatives and compositions thereof
IL51865A0 (en) New fluoroacylresorcin derivatives their preparation and compositions containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
IL55555A0 (en) Novel 3-phenyl-azacycloalkane derivatives and their preparation
NZ187272A (en) Alkylenediamine derivatives and pharmaceutical compositions
IL60139A0 (en) Novel 3-vinyl-cephalosporin derivatives and their preparation
NZ194348A (en) Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
GB2042892B (en) Compositions of dispersability and preparation thereof
NZ186335A (en) Oxadizolopyrimidine derivatives and pharmazeutical compositions
GB2050349B (en) Isonicotinoyl derivatives of aminoacids
NZ185287A (en) Derivatives of bis-carbamoyl sulphides and desticidal compositions
GB2051794B (en) Hydroxyamino-eburnane derivatives their preparation and use pharmalceutical compositions containing them and intermediates therefor
PT71537A (en) Compositions of matter
GB2055370B (en) Ergol-8-ene and ergoline derivatives
DE3064789D1 (en) New 25-hydroxy-24-oxocholestane derivatives and preparation thereof
NZ193557A (en) 4-phenylchroman derivatives intermediates and pharmaceutical compositions
JPS5371042A (en) Preparation of styrenized diphenylamine
PH15451A (en) Benzothiazole derivatives and compositions containing same
GB2001980B (en) Dioxazocine derivatives their preparation and compositions containing them
JPS5639067A (en) Pyrrolidineedione derivatives and mildewcidal composition containing them
GB2044258B (en) Quinoline derivatives useful as antioxidants their preparation and compositions containing them
NZ185779A (en) Derivatives of ortho-aminoacetophenone and pharaceutical compositions